Alpha-synuclein propagation: New insights from animal models

被引：96

作者：

Dehay, Benjamin ^{[1
,2
]}

Vila, Miquel ^{[3
,4
,5
]}

Bezard, Erwan ^{[1
,2
]}

Brundin, Patrik ^{[6
]}

Kordower, Jeffrey H. ^{[7
]}

机构：

[1] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33076 Bordeaux, France

[2] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France

[3] Vall dHebron Res Inst, Neurodegenerat Dis Res Grp, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Barcelona, Spain

[4] Autonomous Univ Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain

[5] Catalan Inst Res & Adv Studies, Barcelona, Spain

[6] Van Andel Res Inst, Ctr Neurodegenerat Sci, Lab Translat Parkinsons Dis Res, Grand Rapids, MI USA

[7] Rush Univ, Dept Neurol Sci, Grad Coll, Chicago, IL 60612 USA

来源：

MOVEMENT DISORDERS | 2016年 / 31卷 / 02期

关键词：

alpha-synuclein; propagation; synucleinopathy; Parkinson's disease; animal models; MULTIPLE SYSTEM ATROPHY; TO-NEURON TRANSMISSION; PARKINSONS-DISEASE; TRANSGENIC MICE; INCLUSION FORMATION; PATHOLOGY SPREAD; MUTATION; BRAIN; OLIGOMERS; FIBRILS;

D O I：

10.1002/mds.26370

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Aggregation of alpha-synuclein is implicated in several neurodegenerative diseases collectively termed synucleinopathies. Emerging evidence strongly implicates cell-to-cell transmission of misfolded alpha-synuclein as a common pathogenetic mechanism in synucleinopathies. The impact of alpha-synuclein pathology on neuronal dysfunction and behavioral impairments is being explored in animal models. This review provides an update on how research in animal models supports the concept that misfolded alpha-synuclein spreads from cell to cell and describes how findings in animal models might relate to the disease process in humans. Finally, we discuss the current underlying molecular and cellular mechanisms and future therapeutic strategies targeting alpha-synuclein propagation. (c) 2015 International Parkinson and Movement Disorder Society

引用

页码：161 / 168

页数：8

共 50 条

[31] Novel Insights into Impairment of Membrane Integrity by Alpha-Synuclein Oligomers
Stockl, Martin T.
Claessens, Mireille M. A. E.
Subramaniam, Vinod
BIOPHYSICAL JOURNAL, 2012, 102 (03) : 256A - 257A
[32] Ubiquitination of alpha-synuclein
Nonaka, T
Iwatsubo, T
Hasegawa, M
NEUROBIOLOGY OF AGING, 2004, 25 : S469 - S469
[33] Structural and Functional Insights Into Lipid Binding by Oligomeric Alpha-Synuclein
van Rooijen, Bart
van Leijenhorst-Groener, Kirsten A.
Claessens, Mireille M. A. E.
Subramaniam, Vinod
BIOPHYSICAL JOURNAL, 2010, 98 (03) : 653A - 654A
[34] The Small Molecule Alpha-Synuclein Aggregator, FN075, Enhances Alpha-Synuclein Pathology in Subclinical AAV Rat Models
Kelly, Rachel
Cairns, Andrew G.
Aden, Jorgen
Almqvist, Fredrik
Bemelmans, Alexis-Pierre
Brouillet, Emmanuel
Patton, Tommy
McKernan, Declan P.
Dowd, Eilis
BIOMOLECULES, 2021, 11 (11)
[35] How is alpha-synuclein cleared from the cell?
Stefanis, Leonidas
Emmanouilidou, Evangelia
Pantazopoulou, Marina
Kirik, Deniz
Vekrellis, Kostas
Tofaris, George K.
JOURNAL OF NEUROCHEMISTRY, 2019, 150 (05) : 577 - 590
[36] Modulation of the expression and aggregation of alpha-synuclein and of erp57 in cellular and animal models of Parkinson disease
Aureli, C.
Francioso, A.
Masci, A.
Faraldi, M.
Martire, S.
Ferraro, A.
Fontana, M.
Cassano, T.
D'Erme, M.
Mosca, L.
FEBS JOURNAL, 2011, 278 : 257 - 257
[37] Alpha-synuclein: from secretion to dysfunction and death
Marques, O.
Outeiro, T. F.
CELL DEATH & DISEASE, 2012, 3 : e350 - e350
[38] Alpha-Synuclein Transfers from Neurons to Oligodendrocytes
Reyes, Juan F.
Rey, Nolwen L.
Bousset, Luc
Melki, Ronald
Brundin, Patrik
Angot, Elodie
GLIA, 2014, 62 (03) : 387 - 398
[39] Alpha-synuclein: from secretion to dysfunction and death
O Marques
T F Outeiro
Cell Death & Disease, 2012, 3 : e350 - e350
[40] Drug Targets from Genetics: Alpha-Synuclein
Danzer, Karin M.
McLean, Pamela J.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (06) : 712 - 723

← 1 2 3 4 5 →